Metabolomics and breast cancer: scaling up for robust results.
作者信息
Moore Steven C
机构信息
Metabolic Epidemiology Branch, Division of Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Dr, Bethesda, MD, 20892, USA.
出版信息
BMC Med. 2020 Jan 31;18(1):18. doi: 10.1186/s12916-019-1484-5.
Abstract
摘要
相似文献
1
Metabolomics and breast cancer: scaling up for robust results.代谢组学与乳腺癌：扩大规模以获得可靠结果
BMC Med. 2020 Jan 31;18(1):18. doi: 10.1186/s12916-019-1484-5.
2
Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer.计算模型应用于代谢组学数据提示谷氨酰胺代谢在乳腺癌中的相关性。
BMC Cancer. 2020 Apr 15;20(1):307. doi: 10.1186/s12885-020-06764-x.
3
Metabolomic studies of breast cancer in murine models: A review.基于鼠模型的乳腺癌代谢组学研究综述。
Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165713. doi: 10.1016/j.bbadis.2020.165713. Epub 2020 Jan 31.
4
Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.激素反应性和三阴性乳腺癌细胞对紫杉醇反应的代谢组学分析确定关键代谢差异
J Proteome Res. 2016 Sep 2;15(9):3225-40. doi: 10.1021/acs.jproteome.6b00430. Epub 2016 Aug 3.
5
Metabotypes of breast cancer cell lines revealed by non-targeted metabolomics.非靶向代谢组学揭示乳腺癌细胞系的代谢表型。
Metab Eng. 2017 Sep;43(Pt B):173-186. doi: 10.1016/j.ymben.2016.12.009. Epub 2016 Dec 27.
6
Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomics.通过靶向代谢组学和脂质组学在小鼠转移性乳腺癌的血浆中检测到精氨酸和能量代谢、结构和信号脂质的改变。
Breast Cancer Res. 2018 Dec 4;20(1):148. doi: 10.1186/s13058-018-1075-y.
7
Metabolomics and lipidomics study unveils the impact of polybrominated diphenyl ether-47 on breast cancer mice.代谢组学和脂质组学研究揭示多溴联苯醚-47 对乳腺癌小鼠的影响。
J Hazard Mater. 2020 May 15;390:121451. doi: 10.1016/j.jhazmat.2019.121451. Epub 2019 Oct 13.
8
Metabolomics reveals the effect of valproic acid on MCF-7 and MDA-MB-231 cells.代谢组学揭示了丙戊酸对MCF - 7和MDA - MB - 231细胞的影响。
Xenobiotica. 2020 Mar;50(3):252-260. doi: 10.1080/00498254.2019.1618510. Epub 2019 Jun 4.
9
Alterations of the exo- and endometabolite profiles in breast cancer cell lines: A mass spectrometry-based metabolomics approach.乳腺癌细胞系中外源和内源性代谢物谱的改变：基于质谱的代谢组学方法。
Anal Chim Acta. 2016 Jun 21;925:34-42. doi: 10.1016/j.aca.2016.04.047. Epub 2016 Apr 28.
10
Metabolomics reveals metabolic targets and biphasic responses in breast cancer cells treated by curcumin alone and in association with docetaxel.代谢组学揭示了姜黄素单独和联合多西紫杉醇处理乳腺癌细胞的代谢靶点和双相反应。
PLoS One. 2013;8(3):e57971. doi: 10.1371/journal.pone.0057971. Epub 2013 Mar 5.
引用本文的文献
1
Prospective study of circulating metabolomic profiles and breast cancer incidence among predominantly premenopausal women.主要针对绝经前女性的循环代谢组学特征与乳腺癌发病率的前瞻性研究。
Br J Cancer. 2025 Sep 4. doi: 10.1038/s41416-025-03159-2.
2
ENPP2 promotes progression and lipid accumulation via AMPK/SREBP1/FAS pathway in chronic lymphocytic leukemia.ENPP2通过AMPK/SREBP1/FAS途径促进慢性淋巴细胞白血病的进展和脂质积累。
Cell Mol Biol Lett. 2024 Dec 27;29(1):159. doi: 10.1186/s11658-024-00675-6.
3
Trends and associated factors of mental health diagnoses in Catalan Primary Care (2010-2019).加泰罗尼亚初级保健中精神健康诊断的趋势及相关因素（2010 - 2019年）
Eur Psychiatry. 2024 Dec 10;67(1):e81. doi: 10.1192/j.eurpsy.2024.1793.
4
Nutritional Metabolomics in Diet-Breast Cancer Relations: Current Research, Challenges, and Future Directions-A Review.饮食与乳腺癌关系中的营养代谢组学：当前研究、挑战及未来方向——综述
Biomedicines. 2023 Jun 27;11(7):1845. doi: 10.3390/biomedicines11071845.
5
A prospective case-cohort analysis of plasma metabolites and breast cancer risk.前瞻性病例-队列分析血浆代谢物与乳腺癌风险。
Breast Cancer Res. 2023 Jan 17;25(1):5. doi: 10.1186/s13058-023-01602-x.
6
Insulinemic potential of diet and risk of total and subtypes of breast cancer among US females.饮食的胰岛素生成潜力与美国女性乳腺癌总发病风险和亚型发病风险的关系。
Am J Clin Nutr. 2022 Dec 19;116(6):1530-1539. doi: 10.1093/ajcn/nqac284.
7
Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort.生活方式与八种乳腺癌相关代谢物的相关性：一项在 EPIC 队列内的横断面研究。
BMC Med. 2021 Dec 10;19(1):312. doi: 10.1186/s12916-021-02183-2.
8
A Metabolomics Analysis of Postmenopausal Breast Cancer Risk in the Cancer Prevention Study II.癌症预防研究II中绝经后乳腺癌风险的代谢组学分析。
Metabolites. 2021 Feb 10;11(2):95. doi: 10.3390/metabo11020095.
本文引用的文献
1
Prospective analysis of circulating metabolites and breast cancer in EPIC.前瞻性分析 EPIC 中的循环代谢物与乳腺癌。
BMC Med. 2019 Sep 24;17(1):178. doi: 10.1186/s12916-019-1408-4.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018：GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
Role of carnitine and its derivatives in the development and management of type 2 diabetes.肉碱及其衍生物在 2 型糖尿病的发生发展和治疗中的作用。
Nutr Diabetes. 2018 Mar 7;8(1):8. doi: 10.1038/s41387-018-0017-1.
4
NMR metabolomic signatures reveal predictive plasma metabolites associated with long-term risk of developing breast cancer.NMR 代谢组学特征揭示了与乳腺癌发生长期风险相关的预测性血浆代谢物。
Int J Epidemiol. 2018 Apr 1;47(2):484-494. doi: 10.1093/ije/dyx271.
5
A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk.体质量指数与绝经后乳腺癌风险的代谢组学分析
J Natl Cancer Inst. 2018 Jun 1;110(6):588-597. doi: 10.1093/jnci/djx244.
6
Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study.在一项前瞻性代谢组学研究中，血浆中溶血磷脂酰胆碱18:0水平较高与常见癌症风险较低相关。
BMC Med. 2016 Jan 28;14:13. doi: 10.1186/s12916-016-0552-3.
7
Cancer metabolism: fatty acid oxidation in the limelight.癌症代谢：脂肪酸氧化备受关注。
Nat Rev Cancer. 2013 Apr;13(4):227-32. doi: 10.1038/nrc3483. Epub 2013 Feb 28.
8
Metabolite profiles and the risk of developing diabetes.代谢产物谱与糖尿病发病风险。
Nat Med. 2011 Apr;17(4):448-53. doi: 10.1038/nm.2307. Epub 2011 Mar 20.
9
Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease.乳腺癌与母乳喂养：对来自30个国家的47项流行病学研究的个体数据进行的联合重新分析，其中包括50302名乳腺癌患者和96973名未患该病的女性。
Lancet. 2002 Jul 20;360(9328):187-95. doi: 10.1016/S0140-6736(02)09454-0.
Zotero 插件